Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who are leading the development of next-generation antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.
Company Details
- Employees
- 89
- Address
- 7 Times Square, Floor 43, New York City,new York,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://dianthustx.com
- HQ
- New York City, New York
Dianthus Therapeutics, Inc. Questions
Dianthus Therapeutics, Inc.'s website is https://dianthustx.com
Dianthus Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/dianthus-therapeutics-inc
Dianthus Therapeutics, Inc. has
89 employees.
View email and phone details for 89
employees at Dianthus Therapeutics, Inc..
Dianthus Therapeutics, Inc.'s industry is
Biotechnology Research
Dianthus Therapeutics, Inc.'s top competitors are
Envisagenics,
Immunic Therapeutics,
Anavex Life Sciences,
Tourmaline Bio,
Lexeo Therapeutics,
Gilgamesh Pharmaceuticals,
Royalty Pharma,
Biospherix, Llc,
Nuvation Bio,
Applied Therapeutics, Inc..
Dianthus Therapeutics, Inc.'s categories are Biotechnology Research
